Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
I
Indraprastha Medical Corporation Ltd
Score 68/100• Decent
Indraprastha Medical Corporation Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
Company’s Health82/100
Valuation 20/100 · PB 7.2341
Technical Avoid
1M -17.538% 6M 14.548% 1Y -2.556%
Confidence100%
Low leverage (D/E)No promoter pledge
#61
View details ➜
E
Emcure Pharmaceuticals Ltd
Score 68/100• Decent
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
Company’s Health85/100
Valuation 20/100 · PB 5.8754
Technical Avoid
1M 3.094% 6M 4.557% 1Y 6.919%
Confidence100%
Low leverage (D/E)Decent revenue growth
Promoter pledge present
#62
View details ➜
P
PREVEST DENPRO LTD
Score 68/100• Decent
The stock shows potential but faces challenges in growth consistency and valuation metrics.
Company’s Health98/100
Valuation 20/100 · PB 5.3432
Technical Avoid
1M -8.325% 6M -1.961% 1Y -18.27%
Confidence100%
Low leverage (D/E)No promoter pledge
#63
View details ➜
P
Parnax Lab Ltd
Score 68/100• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
Company’s Health63/100
Valuation 80/100 · PB 1.7351
Technical Avoid
1M -14.211% 6M 18.008% 1Y -24.837%
Confidence100%
Reasonable PB valuation
Promoter pledge presentThin margins
#64
View details ➜
O
Omkar Pharmachem Ltd
Score 68/100• Decent
Omkar Pharmachem Ltd shows potential but faces several challenges that may hinder growth.
Company’s Health68/100
Valuation 60/100 · PB 2.9998
Technical Avoid
1M 4.775% 6M -6.5% 1Y 0.972%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#65
View details ➜
M
Medicamen Organics Ltd
Score 68/100• Decent
Medicamen Organics Ltd shows potential for growth but faces several challenges that could impact its performance.
Company’s Health94/100
Valuation 100/100 · PB 0.998
Technical Avoid
1M -7.143% 6M -42.414% 1Y -56.522%
Confidence100%
Low leverage (D/E)No promoter pledge
#66
View details ➜
M
Medicamen Biotech Ltd
Score 68/100• Decent
Medicamen Biotech Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health62/100
Valuation 60/100 · PB 2.5789
Technical Avoid
1M -3.326% 6M -3.225% 1Y -29.123%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#67
View details ➜
M
Medi-Caps Ltd
Score 68/100• Decent
Medi-Caps Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised.
Company’s Health51/100
Valuation 100/100 · PB 0.3286
Technical Avoid
1M -24.192% 6M -25.148% 1Y -37.609%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#68
View details ➜
M
Medi Assist Healthcare Services Ltd
Score 68/100• Decent
Medi Assist Healthcare Services Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
Company’s Health79/100
Valuation 20/100 · PB 6.3277
Technical Avoid
1M 0.597% 6M -5.574% 1Y -22.992%
Confidence100%
Low leverage (D/E)No promoter pledge
#69
View details ➜
I
Indegene Ltd
Score 68/100• Decent
Indegene Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.
Company’s Health80/100
Valuation 20/100 · PB 5.2812
Technical Avoid
1M 0.802% 6M 6.526% 1Y -13.298%
Confidence100%
Low leverage (D/E)No promoter pledge
#70
View details ➜
F
Fredun Pharmaceuticals Ltd
Score 68/100• Decent
Fredun Pharmaceuticals Ltd shows potential for growth but carries risks that need to be monitored closely.
Company’s Health72/100
Valuation 20/100 · PB 6.1469
Technical Avoid
1M -7.352% 6M 97.817% 1Y 114.101%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#71
View details ➜
B
Bajaj Healthcare Ltd
Score 68/100• Decent
Bajaj Healthcare Ltd shows potential in a growing sector, but inconsistencies in growth and profitability metrics warrant caution.
Company’s Health67/100
Valuation 60/100 · PB 2.7982
Technical Avoid
1M -5.835% 6M -21.55% 1Y -5.199%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#72
View details ➜
A
Anuh Pharma Ltd
Score 68/100• Decent
Anuh Pharma Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health87/100
Valuation 60/100 · PB 2.438
Technical Avoid
1M -4.693% 6M -26.381% 1Y -28.825%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#73
View details ➜
K
Kilitch Drugs (India) Ltd
Score 68/100• Decent
Kilitch Drugs shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health86/100
Valuation 60/100 · PB 2.9793
Technical Avoid
1M -7.662% 6M -23.192% 1Y 8.021%
Confidence100%
Low leverage (D/E)No promoter pledge
#74
View details ➜
G
Gujarat Terce Laboratories Ltd
Score 68/100• Decent
Gujarat Terce Laboratories Ltd shows decent potential but faces challenges in profitability and valuation. Investors should proceed with caution.
Company’s Health49/100
Valuation 20/100 · PB 5.106
Technical Avoid
1M -1.111% 6M -19.473% 1Y -49.285%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#75
View details ➜
Showing 61 to 75 of 301 (21 Pages)